Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DMRA | CCEC |
|---|---|---|
| Price | $20.22 | $20.70 |
| Change today | ▼ 2.08% | ▼ 1.38% |
| Market cap | $1.25B | $1.25B |
| Return, 3 months | -32.6% | -6.6% |
| Return, year to date | -12.1% | +1.3% |
| Return, 1 year | +445.0% | -3.7% |
| P/E (TTM) | -77.8 | 8.0 |
| P/B | 3.2 | 0.8 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 2.90% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 31 | 43 |
| 30-day volatility | 69.8% | 59.9% |
| Max drawdown, 1 year | -72.4% | -26.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
